[HTML][HTML] Assessing the need for adjuvant chemotherapy after stereotactic body radiation therapy in early-stage non-small cell lung carcinoma
R Jumeau, H Bahig, É Filion, MP Campeau, L Lambert… - Cureus, 2016 - ncbi.nlm.nih.gov
Purpose Surgery remains the standard treatment for medically operable patients with early-
stage non-small cell lung carcinoma (NSCLC). Following surgical resection, adjuvant …
stage non-small cell lung carcinoma (NSCLC). Following surgical resection, adjuvant …
FDG-PET and stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer
DJ Hoopes, M Tann, JW Fletcher, JA Forquer, PF Lin… - Lung cancer, 2007 - Elsevier
PURPOSE: To investigate the utility of positron emission tomography (PET) in patients
treated with stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer …
treated with stereotactic body radiotherapy (SBRT) for stage I non-small-cell lung cancer …
Imaging features associated with disease progression after stereotactic ablative radiotherapy for stage I non–small-cell lung cancer
Abstract Introduction/Background The aim of this study was to identify imaging-based
predictors of progression in patients treated with SABR for stage I NSCLC. Patients and …
predictors of progression in patients treated with SABR for stage I NSCLC. Patients and …
Update of a prospective study of stereotactic body radiation therapy for post-chemoradiation residual disease in stage II/III non-small cell lung cancer
S Kumar, J Feddock, X Li, AJ Shearer, L Hall… - International Journal of …, 2017 - Elsevier
Purpose To report long-term outcomes (risk of late toxicities, local control, and survival) of
dose escalation by stereotactic radiation therapy boost to residual fluorodeoxyglucose …
dose escalation by stereotactic radiation therapy boost to residual fluorodeoxyglucose …
Prognostic value of pretreatment FDG-PET parameters in high-dose image-guided radiotherapy for oligometastatic non–small-cell lung cancer
Background Emerging data support aggressive local treatment of oligometastatic non–small-
cell lung cancer (NSCLC) patients. We sought to determine whether the metabolic burden of …
cell lung cancer (NSCLC) patients. We sought to determine whether the metabolic burden of …
Recurrence patterns and second primary lung cancers after stereotactic body radiation therapy for early-stage non–small-cell lung cancer: implications for surveillance
Background Patients treated with stereotactic body radiation therapy (SBRT) for early-stage
non–small-cell lung cancer (NSCLC) are subject to locoregional and distant recurrence, as …
non–small-cell lung cancer (NSCLC) are subject to locoregional and distant recurrence, as …
Parenchymal and Functional lung changes after stereotactic Body radiotherapy for early-stage non-small cell lung cancer—experiences from a single institution
Introduction This study aimed to evaluate parenchymal and functional lung changes
following stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer …
following stereotactic body radiotherapy (SBRT) for early-stage non-small cell lung cancer …
Predicting 5-year progression and survival outcomes for early stage non-small cell lung cancer treated with stereotactic ablative radiation therapy: development and …
Purpose Our purpose was to develop predictive nomograms for overall survival (OS),
progression-free survival (PFS), and time-to-progression (TTP) at 5 years in patients with …
progression-free survival (PFS), and time-to-progression (TTP) at 5 years in patients with …
Role of stereotactic body radiotherapy for early‐stage non‐small‐cell lung cancer in patients borderline for surgery due to impaired pulmonary function
N Tomita, K Okuda, N Kita, M Niwa… - Asia‐Pacific Journal …, 2022 - Wiley Online Library
Aim Stereotactic body radiotherapy (SBRT) is recommended only for inoperable patients
with early‐stage (e‐stage) non‐small‐cell lung cancer (NSCLC). We compared outcomes …
with early‐stage (e‐stage) non‐small‐cell lung cancer (NSCLC). We compared outcomes …
Combination of Clinical Factors and Radiomics Can Predict Local Recurrence and Metastasis After Stereotactic Body Radiotherapy for Non-small Cell Lung Cancer
Y Isoyama-Shirakawa, T Yoshitake… - Anticancer …, 2023 - ar.iiarjournals.org
Background/Aim: Radiomics, which links radiological image features with patient prognoses,
is expected to be applied for the prediction of the clinical outcomes of radiotherapy. We …
is expected to be applied for the prediction of the clinical outcomes of radiotherapy. We …